Terms: = Ovarian cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Prognosis
2 results:
1. Clinicopathological Features of BRCA1/2 Mutation-Positive Breast cancer.
Paik HJ; Jung YJ; Kim DI; Lee S; Jung CS; Kang SK; Kim JJ; Oh SY; Joo JH; Kim HY
Oncology; 2021; 99(8):499-506. PubMed ID: 34098565
[TBL] [Abstract] [Full Text] [Related]
2. Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma.
Hu J; Jiao X; Zhu L; Guo H; Wu Y
BMC Cancer; 2020 Sep; 20(1):938. PubMed ID: 32993522
[TBL] [Abstract] [Full Text] [Related]
